These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7488277)

  • 1. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial.
    Buchbinder R; Bombardier C; Yeung M; Tugwell P
    Arthritis Rheum; 1995 Nov; 38(11):1568-80. PubMed ID: 7488277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
    Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.
    Am J Med; 1995 Feb; 98(2):156-68. PubMed ID: 7847432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V; Tugwell P; Bombardier C; Maetzel A; Crawford B; Dorrier C; Thompson A; Wells G
    Arthritis Rheum; 1999 Sep; 42(9):1870-8. PubMed ID: 10513801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, multicenter, controlled clinical trial of cyclosporine plus chloroquine vs. cyclosporine plus placebo in early-onset rheumatoid arthritis.
    Miranda JM; Alvarez-Nemegyei J; Saavedra MA; Terán L; Galván-Villegas F; García-Figueroa J; Jara LJ; Barile L;
    Arch Med Res; 2004; 35(1):36-42. PubMed ID: 15036798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.
    Felson DT; Anderson JJ; Boers M; Bombardier C; Chernoff M; Fried B; Furst D; Goldsmith C; Kieszak S; Lightfoot R
    Arthritis Rheum; 1993 Jun; 36(6):729-40. PubMed ID: 8507213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis.
    Verhoeven AC; Boers M; van Der Linden S
    Ann Rheum Dis; 2000 Dec; 59(12):966-74. PubMed ID: 11087700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.
    Pincus T; Richardson B; Strand V; Bergman MJ
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-47-54. PubMed ID: 25365089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.
    Tuttleman M; Pillemer SR; Tilley BC; Fowler SE; Buckley LM; Alarcón GS; Trentham DE; Neuner R; Clegg DO; Leisen JC; Heyse SP
    J Rheumatol; 1997 Oct; 24(10):1910-5. PubMed ID: 9330931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T; Amara I; Koch GG
    Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.
    Paulus HE; Bulpitt KJ; Ramos B; Park G; Wong WK;
    Arthritis Rheum; 2000 Dec; 43(12):2743-50. PubMed ID: 11145032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of the traditional Chinese medicine Juanbi pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial.
    Wang Q; Wang YR; Jia QY; Liu L; Xu CQ; Wang XY; Yao M; Cui XJ; Shi Q; Wang YJ; Liang QQ
    Trials; 2018 Mar; 19(1):188. PubMed ID: 29558967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?
    Ward MM
    J Rheumatol; 1994 Jan; 21(1):17-27. PubMed ID: 7864914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and documentation of rheumatoid arthritis disease status in the clinic: which variables best predict change in therapy.
    Wolfe F; Pincus T; O'Dell J
    J Rheumatol; 2001 Jul; 28(7):1712-7. PubMed ID: 11469486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The American College of Rheumatology (ACR) Core Data Set and derivative "patient only" indices to assess rheumatoid arthritis.
    Pincus T
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S109-13. PubMed ID: 16273794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous administration of polymerized-type I collagen for the treatment of patients with rheumatoid arthritis. An open-label pilot trial.
    Furuzawa-Carballeda J; Cabral AR; Zapata-Zuñiga M; Alcocer-Varela J
    J Rheumatol; 2003 Feb; 30(2):256-9. PubMed ID: 12563677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial.
    Javadi F; Ahmadzadeh A; Eghtesadi S; Aryaeian N; Zabihiyeganeh M; Rahimi Foroushani A; Jazayeri S
    J Am Coll Nutr; 2017 Jan; 36(1):9-15. PubMed ID: 27710596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.